neutropenia
Terbinafine is in a class of
Terbinafine is formulated as a 250 mg tablet to be taken by mouth
It is freely soluble in methanol and methylene chloride, soluble in ethanol, and slightly soluble in water
It works by stopping the growth of fungus Terbinafine Side Effects Print Save Terbinafine Side Effects Medically reviewed by Drugs
This medication is also used to treat a skin condition known
What is terbinafine used for? Terbinafine is an antifungal medication used to treat certain types of fungal and yeast infections
Check with your doctor right away if you start having nausea or vomiting, dark urine, light-colored stools, stomach pain, or yellow eyes or skin while you or your child are using this medicine
Tablet, 250 mg light pink with mottled surface, round, biconvex tablet debossed with “501” on one side and plain on the other side
AN 543
250 mg/day orally in a single dose or divided every 12 hours for 2-4 week Terbinafine HCl
Terbinafine tablets are contraindicated in patients with: Chronic or active liver disease [see Warnings and Precautions (5
USE COUPON
Terbinafine tablets are usually taken with or without food once a day for 6 weeks for fingernail infections and once a day for 12 weeks for toenail infections
Terbinafine tablets are contraindicated in patients with: Chronic or active liver disease [see Warnings and Precautions (5
Terbinafine is used in the treatment of Onychomycosis, Toenail; Tinea Capitis; Cutaneous Candidiasis; Onychomycosis, Fingernail; Tinea
A
ATC Code D01BA Antifungals for systemic use D01BA02 terbinafine
11% of reviewers reported a positive experience, while 78% reported a negative experience
Baddley
Terbinafine is used in the treatment of Onychomycosis, Toenail; Tinea Capitis; Cutaneous Candidiasis; Onychomycosis, Fingernail; Tinea Corporis and belongs to the
It is freely soluble in methanol and methylene chloride, soluble in ethanol, and slightly soluble in water
It is freely soluble in methanol and methylene chloride, soluble in ethanol, and slightly soluble in water
Objective: To evaluate the effectiveness and safety of 250 mg terbinafine for the treatment of cutaneous sporotrichosis in patients in whom itraconazole use is not possible